Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials (Q91853)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials |
scientific article |
Statements
31
0 references
6
0 references
572-578
0 references
November 2010
0 references
A.P. Mander
0 references
S.G. Thompson
0 references
